Walgreens Boots Alliance (NASDAQ:WBA) issued its quarterly earnings results on Wednesday. The pharmacy operator reported $1.22 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.03 by $0.19, MarketWatch Earnings reports. The business had revenue of $36.31 billion during the quarter, compared to the consensus estimate of $35.01 billion. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.37 EPS.
NASDAQ WBA traded up $0.64 during midday trading on Friday, hitting $45.90. The company had a trading volume of 271,446 shares, compared to its average volume of 11,145,039. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. The stock has a market cap of $39.65 billion, a price-to-earnings ratio of 91.50, a P/E/G ratio of 1.52 and a beta of 0.44. The firm has a fifty day simple moving average of $40.18 and a two-hundred day simple moving average of $39.23. Walgreens Boots Alliance has a fifty-two week low of $33.36 and a fifty-two week high of $56.80.
The business also recently declared a quarterly dividend, which was paid on Friday, December 11th. Shareholders of record on Thursday, November 19th were given a $0.4675 dividend. The ex-dividend date of this dividend was Wednesday, November 18th. This represents a $1.87 annualized dividend and a yield of 4.07%. Walgreens Boots Alliance’s dividend payout ratio is 39.45%.
Several equities research analysts recently commented on WBA shares. Mizuho reduced their price target on shares of Walgreens Boots Alliance from $43.00 to $37.00 and set a “neutral” rating for the company in a research report on Friday, September 11th. TheStreet upgraded shares of Walgreens Boots Alliance from a “c+” rating to a “b-” rating in a research report on Wednesday, December 9th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Walgreens Boots Alliance from $41.00 to $44.00 and gave the stock a “hold” rating in a research report on Friday. Credit Suisse Group assumed coverage on shares of Walgreens Boots Alliance in a research report on Thursday. They issued a “neutral” rating for the company. Finally, BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Friday, December 18th. Four research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $42.31.
In other news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total transaction of $207,750.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 16.91% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Featured Article: Why is cost of goods sold important?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.